Erratum: Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|17|3048-3048

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.17, 2015-09, pp. : 3048-3048

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The angiotensin receptor blocker valsartan is as effective in reducing the risk of atherosclerotic events as captopril

By  

Inpharma, Vol. 1, Iss. 1531, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Angiotensin II Type 1 Receptor Blocker/Calcium Channel Blocker Combination Therapy for Hypertension: Focus on a Single-pill Fixed-dose Combination of Valsartan and Amlodipine

By Miura S   Saku K  

The Journal of International Medical Research, Vol. 40, Iss. 1, 2012-01 ,pp. : 1-9

Field House Publishing

Access to resources Recommend Favorite

Candesartan: widening indications for this angiotensin II receptor blocker?

By Mendis B   Page SR  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 12, 2009-08 ,pp. : 1995-2007

Informa Healthcare

Access to resources Recommend Favorite

Telmisartan: a Different Angiotensin II Receptor Blocker Protecting a Different Population?

By Burnier M  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 1662-1679

Field House Publishing

Access to resources Recommend Favorite

Reply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab

By  

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 4006-4007

Blackwell Publishing

Access to resources Recommend Favorite